AIM IMMUNOTECH INC. Other Research and Development Expense
AIM IMMUNOTECH INC. (AIM) reported Other Research and Development Expense of $482.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherResearchAndDevelopmentExpense · last filed 2026-05-15
- AIM IMMUNOTECH INC. other research and development expense for the quarter ending 2026-03-31 was $482.00K, a 55.37% decline year-over-year.
- AIM IMMUNOTECH INC. other research and development expense for the quarter ending 2025-12-31 was $1.06M, a 36.12% decline year-over-year.
- AIM IMMUNOTECH INC. other research and development expense for the quarter ending 2025-09-30 was $607.00K, a 57.76% decline year-over-year.
- AIM IMMUNOTECH INC. other research and development expense for the quarter ending 2025-03-31 was $1.08M.
- AIM IMMUNOTECH INC. other research and development expense for fiscal 2025 was $3.92M, a 36.68% decline from fiscal 2024.
- AIM IMMUNOTECH INC. other research and development expense for fiscal 2024 was $6.20M.
| Period end | Other Research and Development Expense 3 month | Other Research and Development Expense 6 month | Other Research and Development Expense 9 month | Other Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $482.00K 10-Q · filed 2026-05-15 | $1.54M derived: sum of 2 quarters · filed 2026-05-15 | $2.15M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.67M derived: sum of 2 quarters · filed 2026-03-27 | $3.92M 10-K · filed 2026-03-27 | |
| 2025-09-30 | $607.00K 10-Q · filed 2025-11-17 | $2.86M 10-Q · filed 2025-11-17 | ||
| 2025-03-31 | $1.08M 10-Q · filed 2026-05-15 | $2.74M derived: sum of 2 quarters · filed 2026-05-15 | $4.18M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $3.10M derived: sum of 2 quarters · filed 2026-03-27 | $6.20M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $1.44M 10-Q · filed 2025-11-17 | $4.53M 10-Q · filed 2025-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |